Autoimmunity in Reproduction

Erin M. Masaba, MD

Autoimmune and rheumatologic diseases are increasingly recognized for their impact on reproductive health, both in terms of fertility and pregnancy outcomes. With advancements in reproductive medicine and our growing understanding of immunologic dysregulation, examining these conditions in the context of reproductive endocrinology has become imperative. Autoimmune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), antiphospholipid antibody syndrome (APS), autoimmune thyroid disease, inflammatory bowel disease (IBD), celiac disease, and type 1 diabetes mellitus, each present unique challenges to patients attempting conception, undergoing assisted reproductive technologies (ART), and managing pregnancy. This special issue seeks to consolidate the current understanding of these diseases in relation to reproductive health and to provide guidance on optimizing fertility and pregnancy management in affected individuals.

Publication History

Article published online:
12 December 2024

• References

• 1 Clowse MEB, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008; 199 (02) 127.e1-127.e6
• 2 Ostensen M, Villiger PM. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol 2007; 29 (02) 185-191
• 3 Cervera R, Balasch J. Bidirectional effects on autoimmunity and reproduction. Hum Reprod Update 2008; 14 (04) 359-366
• 4 Carp HJ, Selmi C, Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. J Autoimmun 2012; 38 (2-3): J266-J274
• 5 Green PH, Jabri B. Coeliac disease. Lancet 2003; 362 (9381): 383-391
• 6 Kornbluth A, Sachar DB. Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010; 105 (03) 501-523 , quiz 524
• 7 Alijotas-Reig J, Garrido-Gimenez C. Current concepts and new trends in the diagnosis and management of recurrent miscarriage. Obstet Gynecol Surv 2013; 68 (06) 445-466
• 8 Patterson CC, Harjutsalo V, Rosenbauer J. et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study. Diabetologia 2019; 62 (03) 408-417
• 9 Oktay K, Harvey BE, Partridge AH. et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 2018; 36 (19) 1994-2001
• 10 Loren AW, Senapati S. Fertility preservation in patients with hematologic malignancies and recipients of hematopoietic cell transplants. Blood 2019; 134 (09) 746-760
• 11 Anderson RA, Wallace WH. Fertility preservation in girls and young women. Clin Endocrinol (Oxf) 2011; 75 (04) 409-419
• 12 Condorelli M, Demeestere I. Challenges of fertility preservation in non-oncological diseases. Acta Obstet Gynecol Scand 2019; 98 (05) 638-646
• 13 Anderson RA, Amant F, Braat D. et al; ESHRE Guideline Group on Female Fertility Preservation. ESHRE guideline: female fertility preservation. Hum Reprod Open 2020; 2020 (04) hoaa052
• 14 Ruiz-Irastorza G, Khamashta MA. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 2009; 23 (04) 575-582
• 15 Silver R, Craigo S, Porter F, Osmundson SS, Kuller JA, Norton ME. Society for Maternal-Fetal Medicine (SMFM). Electronic address: [e-mail]. Society for Maternal-Fetal Medicine Consult Series #64: systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol 2023; 228 (03) B41-B60